Company Profile
Bone Biologics Stock Price, News & Catalysts
- Ticker:
- BBLG
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.63 USD (+3.50%)
Close
Last updated: August 21, 2026
2.28M USD
Market cap
Why the stock is moving
As of Aug 21, 2026, BBLG closed up 3.50% at $0.6262. No new same-company headline was identified in the current news window.
Company overview
Business overview
Bone Biologics is a biotechnology company focused on bone regeneration and spinal fusion support products. Its story centers on using biologic materials to improve orthopedic healing.
Geographic Base and Sector Classification
Bone Biologics is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and orthopedic biotechnology.
Business Model Characteristics
The company depends on clinical and preclinical progress, product development, and the ability to create a differentiated bone-growth platform. Investors usually watch data, regulatory steps, and capital runway.
Position Within the Biotechnology Landscape
Bone Biologics occupies a small orthopedic-regeneration niche within biotech. The stock is sensitive to whether its biologic platform can translate into meaningful surgical use.
Future catalysts
- Bone Biologics’ catalysts are NELL-1 / spine-regeneration work and any update that shows the platform can still progress clinically. The company remains highly dependent on proof of concept.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bone Biologics (BBLG)?
Bone Biologics (BBLG) most recently closed at 0.63 USD, a +3.50% move versus the previous session.
What is the market cap of Bone Biologics (BBLG)?
Bone Biologics currently has a market capitalization of 2.28M USD on BioPharmSignal.
What does Bone Biologics do?
Bone Biologics is a biotechnology company focused on bone regeneration and spinal fusion support products. Its story centers on using biologic materials to improve orthopedic healing.
On which exchange is BBLG stock listed?
Bone Biologics (BBLG) is associated with NASDAQ, United States, Biopharma.
What is NELL-1?
Bone Biologics’ catalysts are NELL-1 / spine-regeneration work and any update that shows the platform can still progress clinically.
Which conditions is Bone Biologics targeting with NELL-1?
Bone Biologics’ catalysts are NELL-1 / spine-regeneration work and any update that shows the platform can still progress clinically.
How does Bone Biologics describe recent progress with NELL-1?
Bone Biologics’ catalysts are NELL-1 / spine-regeneration work and any update that shows the platform can still progress clinically.
What is Bone?
Bone Biologics is a biotechnology company focused on bone regeneration and spinal fusion support products.